| Dr Sheerli Ratner, PHD | |
|
23376 Lyman Blvd, Shaker Heights, OH 44122-2105 | |
| (216) 470-9532 | |
| Not Available |
| Full Name | Dr Sheerli Ratner |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 14 Years |
| Location | 23376 Lyman Blvd, Shaker Heights, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356633309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 6777 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metrohealth System | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Metrohealth System | 8628982949 | 1026 |
News Archive
Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver.
Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.
Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but little research regarding the emotional toll of screening has been conducted. Researchers from Stony Brook Cancer Center in Stony Brook, New York found 43 percent of patients undergoing LDCT experienced elevated distress before screening, and one-third of patients experienced continued distress even after being told there was no sign of cancer.
› Verified 6 days ago
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver.
Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.
Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but little research regarding the emotional toll of screening has been conducted. Researchers from Stony Brook Cancer Center in Stony Brook, New York found 43 percent of patients undergoing LDCT experienced elevated distress before screening, and one-third of patients experienced continued distress even after being told there was no sign of cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sheerli Ratner, PHD 23376 Lyman Blvd, Shaker Heights, OH 44122-2105 Ph: (216) 470-9532 | Dr Sheerli Ratner, PHD 23376 Lyman Blvd, Shaker Heights, OH 44122-2105 Ph: (216) 470-9532 |
News Archive
Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver.
Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.
Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but little research regarding the emotional toll of screening has been conducted. Researchers from Stony Brook Cancer Center in Stony Brook, New York found 43 percent of patients undergoing LDCT experienced elevated distress before screening, and one-third of patients experienced continued distress even after being told there was no sign of cancer.
› Verified 6 days ago
Dr. Laura Michelle Fogarty, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3294 Van Aken Blvd, Shaker Heights, OH 44120 Phone: 216-647-9382 | |
Dr. Stacy Feiner, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 22001 Fairmount Blvd, Shaker Heights, OH 44118 Phone: 216-320-8222 | |
Mrs. Kelly Lockhart, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17917 Lomond Blvd, Shaker Heights, OH 44122 Phone: 216-295-4050 | |
Jennifer Franklin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20310 Chagrin Blvd, Ste 2, Shaker Heights, OH 44122 Phone: 216-491-9405 Fax: 216-491-8025 | |
Kelly Levandowski, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3638 Townley Rd, Shaker Heights, OH 44122 Phone: 216-832-2467 | |
Mrs. Rasheeda Smialek, SCHOOL PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16824 Holbrook Rd, Shaker Heights, OH 44120 Phone: 216-408-6672 | |
David Tomasik, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20600 Shaker Blvd, Shaker Heights, OH 44122 Phone: 216-295-4034 |